Endymed Medical Ltd. (TASE:ENDY) announced a private placement of 47,934,666 common shares at $0.146 per share with new investor OMK Medical Technology Co. Ltd. for gross proceeds of $6,998,461.236 on June 9, 2014. The investor has an over-allotment option to subscribe for additional 6,847,809 shares at same price. The outstanding shares of the company are 117,725,476. Approval is pending from Tel-Aviv Stock Exchange for listing. The shares to be issued have a hold period of six months, which will start simultaneously from allocation and end on prior to the listing of shares.

On July 14, 2014, the company announced that it has amended the terms of the transaction. The company has cancelled the over-allotment option given to the investor. The company will now issue 6,847,809 unlisted rights to the investor to acquire 6,847,809 shares at a price of $0.146 per share for a total of $999,780.114.

On July 20, 2014, the company announced that it has amended the terms of the transaction. The company will also issue 28,760,800 warrants exercisable into 28,760,800 common shares in the transaction. In case the investor exercises the unlisted rights, the company will issue additional 32,869,485 warrants exercisable into 32,869,485 shares.